CRISPR-TB

About Intelligenome

IntelliGenome is an early-stage diagnostics company leveraging CRISPR technology to build a high-throughput, point-of-care testing platform. The company's core mission is to accelerate disease detection by moving diagnostic capabilities out of centralized labs and into decentralized settings, with an initial focus on tuberculosis (TB). While still in development, its platform promises ultra-sensitive, rapid, and quantitative results for both pathogen identification and monitoring treatment efficacy. The company appears to be in a pre-revenue, R&D-focused stage, collaborating with public health agencies and academic institutions.

Therapeutic Areas